Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to examine and compare the effect of Levosimendan and Milrinone
administered intravenously and via inhalation respectively in cardiac surgery patients with
pulmonary hypertension and right ventricular dysfunction.